Floatz logo

Gadobutrol

Adult Ependymoblastoma

University of Southern CaliforniaSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adult Ependymoblastoma cohort.

Asset / SponsorPhaseRating
Plerixafor
Lawrence Recht
Phase 1/2CCC
rg4733
National Cancer Institute (NCI)
Phase 1C
EF-5
National Cancer Institute (NCI)
Phase 1C
GADOBENATE DIMEGLUMINE
University of Southern California
N/AD

Same molecule, other indications

Gadobutrol is also rated in:

cognitive disorderDormant
BB
Indicative ·
65 / 100
View asset →
Contrast MediaDormant
BB
Indicative ·
65 / 100
View asset →
Magnetic Resonance ImagingDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →